C M Stein

Molecular basis of ethnic differences in drug disposition and response.

R. Kim, C. Stein, C. Stein, 2001, Annual review of pharmacology and toxicology.

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

T E Klein, M Schwab, M. Relling, 2013, Clinical pharmacology and therapeutics.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

T E Klein, L Gong, M Pirmohamed, 2017, Clinical pharmacology and therapeutics.

"No evidence of disease" in rheumatoid arthritis using methotrexate in combination with other drugs: a contemporary goal for rheumatology care?

F. Wolfe, T. Pincus, C. Stein, 1997, Clinical and experimental rheumatology.

Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments].

G R Wilkinson, D M Roden, D. Roden, 1999, Circulation.

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

R L Berg, M Pirmohamed, P. Deloukas, 2010, Clinical pharmacology and therapeutics.

Making medicines safer--the need for an independent drug safety board.

C. Stein, R. Woosley, C M Stein, 1998, The New England journal of medicine.

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

T E Klein, M. Relling, C. Pui, 2011, Clinical pharmacology and therapy.